Financials
- Market Capitalization 4.67 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
29.82
Relación precio/flujo de caja
4.76
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1337 | DFTX Definium Therapeutics, Inc. - Common Shares | 45.85 USD | -0.28% | +1.93% | +93.87% | +203.44% | 5.00 B USD | ||
| 1369 | CRSP CRISPR Therapeutics AG - Common Shares | 50.42 USD | -0.08% | -13.74% | -4.33% | -5.65% | 4.86 B USD | ||
| 1424 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 26.03 USD | +2.12% | +1.64% | +22.03% | +17.89% | 4.46 B USD | ||
| 1432 | LEGN Legend Biotech Corporation - American Depositary Shares | 23.81 USD | -7.25% | -14.51% | -31.99% | -25.55% | 4.40 B USD |